Clinical trial
Pharmacokinetics of IAsp Following CSII in Patients With T1DM
NCT00497536 · University of Aarhus, Other · Completed
Key facts
| NCT number | NCT00497536 |
|---|---|
| Title | Pharmacokinetics of IAsp Following CSII in Patients With T1DM |
| Official title | Pharmacokinetics of Insulin Aspart (IAsp) Following Continuous Subcutaneous Insulin Infusion (CSII) in Patients With Type 1 Diabetes Mellitus (T1DM)- Basal Rate Resolution. |
| Lead sponsor | University of Aarhus, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Insulin Aspart (IAsp), Insulin Aspart (IAsp). |
| Enrollment | 12 |
| Start date | Jul 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jul 6, 2007 |
| Last update posted | Feb 5, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: